We are live on ! Find out more
BMEZ icon

BlackRock Health Sciences Trust II

76 hedge funds and large institutions have $142M invested in BlackRock Health Sciences Trust II in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 24 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 24

22% less funds holding

Funds holding: 9876 (-22)

33.25% less ownership

Funds ownership: 42.66%9.41% (-33%)

61% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 36

78% less capital invested

Capital invested by funds: $643M → $142M (-$501M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
76
Holders Change
-22
Holders Change %
-22.45%
% of All Funds
1%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
14
Increased
20
Reduced
24
Closed
36
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$25.2M -$16.6M -1,163,761 -40%
Bank of America
2
Bank of America
North Carolina
$21M +$1.23M +86,374 +6%
UBS Group
3
UBS Group
Switzerland
$16.7M -$762K -53,327 -4%
PCM
4
Penserra Capital Management
California
$16.5M +$489K +34,191 +3%
Raymond James Financial
5
Raymond James Financial
Florida
$10.1M -$123K -8,595 -1%
Wells Fargo
6
Wells Fargo
California
$9.64M +$404K +28,237 +4%
Invesco
7
Invesco
Georgia
$9.28M -$7.94M -555,752 -46%
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$5.94M -$16.8M -1,177,528 -74%
Stifel Financial
9
Stifel Financial
Missouri
$3.72M -$1.02M -71,312 -21%
LPL Financial
10
LPL Financial
California
$2.69M -$97.5K -6,820 -3%
Osaic Holdings
11
Osaic Holdings
Arizona
$2.06M +$237K +16,555 +13%
Rockefeller Capital Management
12
Rockefeller Capital Management
New York
$1.84M +$147K +10,314 +9%
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$1.61M -$172K -12,053 -10%
Jane Street
14
Jane Street
New York
$1.39M +$851K +59,559 +157%
OC
15
Oppenheimer & Co
New York
$1.15M -$448K -31,365 -28%
Commonwealth Equity Services
16
Commonwealth Equity Services
Massachusetts
$929K -$217K -15,187 -19%
RA
17
RFG Advisory
Alabama
$858K +$859K +60,141 New
FT
18
Fiduciary Trust
Massachusetts
$796K
SPIA
19
Steward Partners Investment Advisory
New York
$774K -$56.2K -3,936 -7%
NA
20
NewEdge Advisors
Louisiana
$689K +$396K +27,686 +134%
BLC
21
Brown, Lisle/Cummings
Rhode Island
$643K +$12.2K +852 +2%
MWM
22
Maridea Wealth Management
New York
$617K +$26.8K +1,874 +5%
EC
23
Elequin Capital
New York
$613K +$543K +37,993 +537%
RAM
24
Readystate Asset Management
Illinois
$461K +$462K +32,313 New
Goldman Sachs
25
Goldman Sachs
New York
$421K +$422K +29,500 New

BMEZ Hedge Fund Activity: Q2 2025 in Review

76 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust II (BMEZ) for Q2 2025, worth a combined $142M — down 78% from $643M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of BMEZ and 14 opened new positions — a net loss of 22 holders — while 24 trimmed existing stakes and 20 added.

The largest buyer was Bank of America, adding an estimated $1.23M. The largest seller was Saba Capital Management, exiting entirely with an estimated $309M sold.

  • 76 institutional investors held BlackRock Health Sciences Trust II (BMEZ) as of Q2 2025, down from 98 in Q1 2025.
  • Funds reported $142M of BlackRock Health Sciences Trust II stock for Q2 2025, down 78% quarter-over-quarter.
  • 14 funds opened new BlackRock Health Sciences Trust II positions in Q2 2025 and 36 closed out, a net change of -22 holders.
  • The largest BlackRock Health Sciences Trust II buyer in Q2 2025 was Bank of America, an estimated $1.23M added.
  • The largest BlackRock Health Sciences Trust II seller in Q2 2025 was Saba Capital Management, an estimated $309M sold.

Based on aggregated 13F filings for Q2 2025.